National Prospective Survey on Women With a Diagnosis of Infiltrative Breast Cancer
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Female
Infiltrative Breast Cancer
Female
Infiltrative Breast Cancer
Trial Information
National Prospective Survey on Women With a Diagnosis of Infiltrative Breast Cancer
Inclusion Criteria:
- Women> or = 18 years old
- Women with newly diagnosis of infiltrative breast cancer
- Agree to take part in this study
Exclusion Criteria:
- Women with other malignant tumor (except in situ cervical carcinoma or treated basal
cell carcinoma)
- Women with in situ ductal carcinoma or in situ lobular carcinoma
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Radiological, Clinical and Histological characteristics
Outcome Time Frame:
Once
Principal Investigator
Alain Castaigne, Medical Director
Investigator Role:
Study Director
Investigator Affiliation:
AstraZeneca
Authority:
France: French Data Protection Authority
Study ID:
NIS-OFR-DUM-2007/1
NCT ID:
NCT00696527
Start Date:
June 2007
Completion Date:
July 2008
Related Keywords:
- Infiltrative Breast Cancer
- Infiltrative breast cancer-Clinical practice
- Women with infiltrative breast cancer
- Breast Neoplasms
Name | Location |
|---|
